Literature DB >> 34150550

Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Intraocular pressure (IOP) modifications in patients with acute central/hemicentral retinal vein occlusions (RVOs) consist in IOP reductions and increases. The IOP reduction is due to a transitional hyposecretory phase of the aqueous humor, that increases gradually until 3mo after the venous occlusion onset, and then finally disappears after month 4th. The IOP increases lead to the ocular hypertension and glaucoma. The possible pathogenetic correlations between ocular hypertension/glaucoma and acute central/hemicentral RVOs have been classified into three groups: 1) the venous occlusion precedes the ocular hypertension/glaucoma causing neovascular glaucoma and secondary angle-closure glaucoma without rubeosis; 2) the ocular hypertension and the glaucoma precede the venous occlusion and favor its appearance (ocular hypertension, primary angle-closure, primary angle-closure glaucoma, and open angle glaucomas); and 3) the venous occlusion and the ocular hypertension/glaucoma are mostly age dependent appearances due to common vascular and collagen alterations, lacking a causal connection between the 2 conditions. International Journal of Ophthalmology Press.

Entities:  

Keywords:  acute central/hemicentral retinal vein occlusion; intraocular pressure; neovascular glaucoma; ocular hypertension; open angle glaucoma; primary angle-closure; secondary nonrubeotic angle-closure glaucoma

Year:  2021        PMID: 34150550      PMCID: PMC8165626          DOI: 10.18240/ijo.2021.06.20

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

Review 1.  Neovascular glaucoma: etiology, diagnosis and prognosis.

Authors:  Tarek A Shazly; Mark A Latina
Journal:  Semin Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.975

2.  COMPARISON OF ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY PARAMETERS BETWEEN CENTRAL RETINAL VEIN OCCLUSION AND NORMAL EYES: Is Primary Angle Closure a Risk Factor for Central Retinal Vein Occlusion?

Authors:  Massood Mohammadi; Fatemeh Bazvand; Ali Makateb; Yadollah Eslami; Mahmood Jabbarvand Behrooz; Ghasem Fakhraie; Reza Zarei; Sasan Moghimi
Journal:  Retina       Date:  2015-09       Impact factor: 4.256

3.  Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.

Authors:  Ke Xu; Lingling Wu; Zhizhong Ma; Yuling Liu; Fang Qian
Journal:  Acta Ophthalmol       Date:  2018-09-21       Impact factor: 3.761

4.  Comment on: 896.

Authors:  D Călugăru; M Călugăru
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

5.  Comment on: Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.

Authors:  Devesh Kumawat; Pranita Sahay; Pooja Shah
Journal:  Am J Ophthalmol       Date:  2019-11-13       Impact factor: 5.258

6.  Comment on: Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.

Authors:  Jagdeep Singh Gandhi
Journal:  Am J Ophthalmol       Date:  2020-01-28       Impact factor: 5.258

7.  Secondary angle-closure glaucoma after central retinal vein occlusion.

Authors:  A D Mendelsohn; L M Jampol; D Shoch
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

8.  Retinal vein occlusion and the optic disk.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Patricia A Podhajsky
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

9.  Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management.

Authors:  Dan Călugăru; Mihai Călugăru; Ştefan Ţălu
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

Review 10.  Neovascular glaucoma: a review.

Authors:  Gustavo B Rodrigues; Ricardo Y Abe; Camila Zangalli; Savio L Sodre; Flavia A Donini; Danilo C Costa; Andre Leite; Joao P Felix; Marcelo Torigoe; Alberto Diniz-Filho; Homero Gusmão de Almeida
Journal:  Int J Retina Vitreous       Date:  2016-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.